`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`______________
`
`RIGEL PHARMACEUTICALS, INC.
`
`Petitioner,
`
`
`v.
`
`
`SERVIER PHARMACEUTICALS LLC
`
`Patent Owner.
`______________
`
`Case No. IPR2022-01423
`Patent: 10,610,125
`
`______________
`
`PATENT OWNER SERVIER PHARMACEUTICALS LLC’S
`MANDATORY NOTICES PURSUANT TO 37 C.F.R. § 42.8(b)
`
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`Patent Owner Servier Pharmaceuticals LLC (“Patent Owner”) hereby files its
`
`IPR2022-01423
`Patent 10,610,125
`
`
`
`Mandatory Notices pursuant to 37 C.F.R. § 42.8(b).
`
`I.
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1))
`Servier Pharmaceuticals LLC is the Patent Owner of the ’125 patent by
`
`assignment. Celgene Corporation, a wholly-owned subsidiary of Bristol-Myers
`
`Squibb Company, is a licensee of the ’125 patent.
`
`II. RELATED MATTERS (37 C.F.R. § 42.8(b)(2))
`At this time, Patent Owner is unaware of any other judicial or administrative
`
`matter that would affect, or be affected by, a decision in this proceeding.
`
`III. LEAD AND BACKUP COUNSEL (37 C.F.R. § 42.8(b)(3))
`The lead counsel for Patent Owner is:
`
`William M. Fink, Reg. No. 72,332
`tfink@omm.com
`O’MELVENY & MYERS LLP
`1625 I Street NW
`Washington D.C. 20006
`(202) 383-5300
`
`The first backup counsel for Patent Owner is:
`
`Joseph D. Eng., Jr., Reg. No. 54,084
`jeng@kslaw.com
`KING & SPALDING LLP
`1185 Avenue of the Americas
`New York, NY 10036
`(212) 556-2205
`
`
`
`
`
`
`
`
`
`
`
`The backup counsel for Patent Owner also are:
`
`IPR2022-01423
`Patent 10,610,125
`
`Jonathan Weinberg, Reg. No. 67,301
`jweinberg@kslaw.com
`KING & SPALDING LLP
`1700 Pennsylvania Ave., NW
`Washington, D.C. 20006
`(202) 626-5583
`
`Vanessa Y. Yen (pro hac vice pending)
`vyen@kslaw.com
`KING & SPALDING LLP
`1185 Avenue of the Americas
`New York, NY 10036
`(212) 556-2212
`
`Evan D. Diamond (pro hac vice pending)
`ediamond@kslaw.com
`KING & SPALDING LLP
`1185 Avenue of the Americas
`New York, NY 10036
`(212) 556-2297
`
`Benjamin Haber, Reg. No. 67,129
`O’MELVENY & MYERS LLP
`bhaber@omm.com
`400 S. Hope Street
`Los Angeles, CA 90071
`(213) 430-6000
`
`Hassen A. Sayeed (pro hac vice pending)
`O’MELVENY & MYERS LLP
`hsayeed@omm.com
`Times Square Tower
`7 Times Square
`New York, NY 10036
`(212) 326-2136
`
`
`-2-
`
`
`
`IPR2022-01423
`Patent 10,610,125
`
`
`
`James Y. Li, Reg. No. 73,052
`O’MELVENY & MYERS LLP
`jli@omm.com
`Times Square Tower
`7 Times Square
`New York, NY 10036
`(212) 728-5929
`
`
`IV. SERVICE INFORMATION (37 C.F.R. § 42.8(b)(4))
`Please address all correspondence to the lead and backup counsel as shown
`
`above. Patent Owner consents to electronic service by email at the email addresses
`
`Respectfully submitted,
`
`KING & SPALDING LLP
`
`
`/Joseph D. Eng, Jr./
`
`Joseph D. Eng, Jr. (Reg. No. 54,084)
`Attorneys for Patent Owner
`Servier Pharmaceuticals LLC
`
`provided above.
`
`
`
`
`
`Date: September 6, 2022
`1185 Avenue of the Americas
`New York, NY 10036
`(212) 556-2100
`
`-3-
`
`
`
`IPR2022-01423
`Patent 10,610,125
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that the foregoing PATENT OWNER’S
`
`
`
`
`
`MANDATORY NOTICES and POWER OF ATTORNEY were served via
`
`electronic mail on September 6, 2022, in their entirety on the following:
`
`Paul H. Berghoff (Reg. No. 30,243)
`James L. Lovsin (Reg. No. 69,550)
`James V. Suggs (Reg. No. 50,419)
`MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
`300 South Wacker Drive
`Chicago, IL 60606
`berghoff@mbhb.com
`lovsin@mbhb.com
`suggs@mbhb.com
`docketing@mbhb.com
`RigelIPR@mbhb.com
`
`
`
`KING & SPALDING LLP
`
`
`/Joseph D. Eng, Jr./
`
`Joseph D. Eng, Jr. (Reg. No. 54,084)
`Attorneys for Patent Owner
`Servier Pharmaceuticals LLC
`
`
`
`
`
`
`
`Date: September 6, 2022
`1185 Avenue of the Americas
`New York, NY 10036
`(212) 556-2100
`
`
`
`